127 related articles for article (PubMed ID: 35939829)
1. The Clinical Significance of Either Extraprostatic Extension or Microscopic Bladder Neck Invasion Alone Versus Both in Men With pT3a Prostate Cancer Undergoing Radical Prostatectomy: A Proposal for a New pT3a Subclassification.
Teramoto Y; Numbere N; Wang Y; Miyamoto H
Am J Surg Pathol; 2022 Dec; 46(12):1682-1687. PubMed ID: 35939829
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Impact of pT3a Lesions in Patients With pT3b Prostate Cancer Undergoing Radical Prostatectomy.
Numbere N; Teramoto Y; Gurung PMS; Goto T; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 May; 146(5):619-625. PubMed ID: 34979562
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Significance of pT3a Lesions as Well as Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Men With pT3b Prostate Cancer: A Proposal for a New pT3b Subclassification.
Teramoto Y; Numbere N; Wang Y; Miyamoto H
Arch Pathol Lab Med; 2023 Nov; 147(11):1261-1267. PubMed ID: 36656173
[TBL] [Abstract][Full Text] [Related]
4. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification.
Rehman A; El-Zaatari ZM; Han SH; Shen SS; Ayala AG; Miles B; Divatia MK; Ketcham MS; Chung BM; Rogers JT; Ro JY
Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
Jeong BC; Chalfin HJ; Lee SB; Feng Z; Epstein JI; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
Eur Urol; 2015 Feb; 67(2):342-6. PubMed ID: 24968968
[TBL] [Abstract][Full Text] [Related]
7. Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassification.
Ball MW; Partin AW; Epstein JI
Urology; 2015 Jan; 85(1):161-4. PubMed ID: 25440818
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
[TBL] [Abstract][Full Text] [Related]
9. Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer.
Park CK; Chung YS; Choi YD; Ham WS; Jang WS; Cho NH
Sci Rep; 2021 Jul; 11(1):13952. PubMed ID: 34230540
[TBL] [Abstract][Full Text] [Related]
10. The significance of microscopic bladder neck invasion in radical prostatectomies: pT4 disease?
Ruano T; Meirelles L; Freitas LL; Magna LA; Ferreira U; Billis A
Int Urol Nephrol; 2009; 41(1):71-6. PubMed ID: 18563619
[TBL] [Abstract][Full Text] [Related]
11. The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted.
Pierorazio PM; Epstein JI; Humphreys E; Han M; Walsh PC; Partin AW
J Urol; 2010 Jan; 183(1):151-7. PubMed ID: 19914651
[TBL] [Abstract][Full Text] [Related]
12. Multifocal Extraprostatic Extension of Prostate Cancer.
Farchoukh L; Laframboise WA; Nelson JB; Bastacky S; Parwani AV; Dhir R
Am J Clin Pathol; 2020 Mar; 153(4):548-553. PubMed ID: 31825470
[TBL] [Abstract][Full Text] [Related]
13. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma.
Cheng L; Darson MF; Bergstralh EJ; Slezak J; Myers RP; Bostwick DG
Cancer; 1999 Nov; 86(9):1775-82. PubMed ID: 10547551
[TBL] [Abstract][Full Text] [Related]
14. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
15. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy.
Shuford MD; Cookson MS; Chang SS; Shintani AK; Tsiatis A; Smith JA; Shappell SB
J Urol; 2004 Jul; 172(1):119-23. PubMed ID: 15201750
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Impact of Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Numbere N; Teramoto Y; Gurung PMS; Wang Y; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 Jul; 146(7):855-861. PubMed ID: 34752605
[TBL] [Abstract][Full Text] [Related]
17. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
[TBL] [Abstract][Full Text] [Related]
18. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
[TBL] [Abstract][Full Text] [Related]
19. Determining the cut-off values of tumor diameter, degree of extraprostatic extension, and extent of surgical margin positivity with regard to biochemical recurrence of prostate cancer after radical prostatectomy.
Kir G; Arikan EA; Seneldir H; Ankarali H; Oznergiz S; Olgun ZC; Yildirim A
Ann Diagn Pathol; 2020 Feb; 44():151431. PubMed ID: 31837592
[TBL] [Abstract][Full Text] [Related]
20. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
Yossepowitch O; Sircar K; Scardino PT; Ohori M; Kattan MW; Wheeler TM; Reuter VE
J Urol; 2002 Nov; 168(5):2011-5. PubMed ID: 12394697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
